Advent Pharma Ltd. (DSE:ADVENT)

Advent Pharma Revenue

In the fiscal year ending June 30, 2025, Advent Pharma had annual revenue of 500.49M BDT, down -12.45%. Advent Pharma had revenue of 150.07M in the quarter ending June 30, 2025, with 16.75% growth.

• Revenue: 500.49M
• Revenue Growth: -12.45%
• P/S Ratio: 2.53
• Revenue / Employee: 1.58M
• Employees: 317
• Market Cap: 1.27B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	500.49M	-71.18M	-12.45%
Jun 30, 2024	571.67M	13.62M	2.44%
Jun 30, 2023	558.05M	27.58M	5.20%
Jun 30, 2022	530.47M	26.87M	5.34%
Jun 30, 2021	503.60M	-30.43M	-5.70%